Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07458256) titled 'The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Tiantan Hospital
Condition:
Laparoscopic Surgery
Liposomal Bupivacaine
Local Infiltration
Intervention:
Drug: Bupivacaine hydrochloride
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 10, 2026
Target Sample Size: 190 ...